Clinical trial
CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation)
NCT00219973 · Rovi Pharmaceuticals Laboratories, Industry · Completed
Key facts
| NCT number | NCT00219973 |
|---|---|
| Title | CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) |
| Official title | Multicentric, Rand., D-b, Pbo Controlled Clinical Trial to Evaluate the Efficacy and the Safety of the Thromboprophylaxis With Bemiparin 3,500 IU/d for 28 Days Compared to 8 Days, in Patients Undergoing Oncological Abdominal/ Pelvic Surgery |
| Lead sponsor | Rovi Pharmaceuticals Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer, Venous Thromboembolism |
| Intervention type | Drug |
| Interventions | Bemiparin |
| Enrollment | 526 |
| Start date | May 1, 2005 |
| Completion | Apr 1, 2009 |
| First posted | Sep 22, 2005 |
| Last update posted | Apr 28, 2010 |
| Countries | Portugal, Romania, Russia, Spain |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: